Ixempra Medicines

Get a Price/Quote

Product Details:

Indication Breast Cancer treatment, particularly metastatic or locally advanced
Dosage Form Injection
Salt Composition Ixabepilone
Feature Cytotoxic agent, ready to use injection
Ingredients Ixabepilone, excipients
Application Oncology/Anticancer therapy
Physical Color/Texture Clear, Colorless to pale yellow liquid
Click to View more

Request to Call Back Send Inquiry

Product Details
Product Description

Ixempra Medicines Price And Quantity

Marketed By Bristol-Myers Squibb
Prescription Required Yes
CAS Number 219989-36-9
Therapeutic Class Antineoplastic
Warning For hospital use only, cytotoxic handling needed
Manufacturing Standard WHO-GMP Certified
Route of Administration Intravenous
Contraindications Hypersensitivity to Ixabepilone or formulation excipients
Packing Type Vial
Strength 15 mg, 45 mg per vial
ATC Code L01D

Ixempra Medicines Product Specifications

Salt Composition Ixabepilone
Shelf Life 2 years from manufacture
Physical Color/Texture Clear, Colorless to pale yellow liquid
Feature Cytotoxic agent, ready to use injection
Storage Instructions Store at 2C to 8C (Refrigerate), Protect from light
Application Oncology/Anticancer therapy
Ingredients Ixabepilone, excipients
Dosage Form Injection
Indication Breast Cancer treatment, particularly metastatic or locally advanced

Marketed By Bristol-Myers Squibb
Prescription Required Yes
CAS Number 219989-36-9
Therapeutic Class Antineoplastic
Warning For hospital use only, cytotoxic handling needed
Manufacturing Standard WHO-GMP Certified
Route of Administration Intravenous
Contraindications Hypersensitivity to Ixabepilone or formulation excipients
Packing Type Vial
Strength 15 mg, 45 mg per vial
ATC Code L01D

Ixempra Medicines Trade Information

Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Product Description

These medicines belong to class of medications called antineoplastic agents. We have been striving to maintain high quality standards in the market by offering Ixempra Medicines. It is used in hospitals and nursing homes for the treatment of advanced breast cancer. We procure these medicines with the help of our agents from reliable vendors. Ixempra Medicines work by preventing abnormal protein activity which signals cancer cells to multiply and spread across the body.

Features:

Slow down cancer cells
Highly effective anti cancer drug
Extended shelf life

Specifications:

Available in: 45 mg

Targeted Anticancer Therapy for Breast Cancer

Ixempra is specifically developed for patients with metastatic or locally advanced breast cancer who may not respond to other treatments. The active ingredient, Ixabepilone, disrupts cancer cell growth, offering a valuable option in oncology. Its use is restricted to healthcare professionals experienced in handling cytotoxic medications, ensuring optimal efficacy and safety in a hospital environment.

Stringent Manufacturing and Handling Standards

Manufactured under WHO-GMP guidelines and marketed by Bristol-Myers Squibb, Ixempra ensures quality and safety throughout its lifecycle. This cytotoxic injection should only be administered intravenously by trained medical personnel, following proper preparation, storage, and disposal protocols. For best results, it must be stored refrigerated (28C) and protected from light.

FAQs of Ixempra Medicines:

Q: How is Ixempra injection administered to patients?

A: Ixempra is administered as an intravenous injection by a qualified healthcare professional in a hospital setting. The dosage and schedule are determined by the oncologist, tailored to each patients needs.

Q: What are the primary indications for Ixempra use?

A: Ixempra is indicated for the treatment of metastatic or locally advanced breast cancer, particularly in patients who have not responded to certain other cancer therapies.

Q: When should Ixempra not be used?

A: Ixempra is contraindicated in individuals with hypersensitivity to Ixabepilone or to any excipient in the formulation. Always inform your doctor about any allergies before starting treatment.

Q: Where should Ixempra be stored before use?

A: The vials of Ixempra should be kept in a refrigerator at 2C to 8C and protected from light. Improper storage can impact the medicines efficacy and safety.

Q: What is the process for handling and disposing of Ixempra vials?

A: As a cytotoxic agent, Ixempra requires careful handling by trained staff in accordance with hospital protocols. Proper protective equipment must be used, and any unused product or waste materials should be disposed of as per local cytotoxic waste guidelines.

Q: What benefits does Ixempra offer in oncology treatment?

A: Ixempra provides an effective option for patients with advanced breast cancer, especially those unresponsive to other therapies. Its valued for its unique mode of action and availability in ready-to-use vial form, streamlining treatment in hospitals.

Q: How can I obtain Ixempra for cancer therapy?

A: Ixempra is a prescription-only medicine distributed, exported, and traded by authorized parties in India. It is available to hospitals and healthcare professionals for use in accordance with oncology treatment protocols.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

Other Products in 'Anti Cancer Injections' category

Reditux Injection Dosage Form : Injection Shelf Life : 24 months from manufacturing date Fermentation Smell : Other, Odorless Salt Composition : Rituximab Physical Color/Texture : Other , Clear to slightly opalescent, colorless to pale yellow solution Indication : NonHodgkins lymphoma, Chronic lymphocytic leukemia, Rheumatoid arthritis, Granulomatosis with polyangiitis Application : Other, Used in oncology and autoimmune disease treatment Ingredients : Other , Rituximab (active), excipients and buffers Storage Instructions : Store at 2C to 8C. Do not freeze. Protect from light. Feature : Other, Chimeric monoclonal antibody, targets CD20 antigen Ph Level : 6.5 7.0 (approximate) Enzyme Types : Other, Not applicable (Monoclonal antibody)

Send Inquiry

Epirubicin EHCL Injection Dosage Form : Injection Shelf Life : 24 Months Fermentation Smell : Other, Odorless Salt Composition : Epirubicin Hydrochloride Physical Color/Texture : Other , Red, clear solution Indication : Treatment of breast cancer and other malignancies Application : Other, IV administration for oncology usage Ingredients : Other , Epirubicin Hydrochloride, Water for Injection, Excipients Storage Instructions : Store below 25C, protect from light Feature : Other, Sterile, readytouse, singledose or multidose vial Ph Level : 3.0 4.5 (approximate)

Send Inquiry

Velcade Injection Dosage Form : Injection Shelf Life : 24 months Fermentation Smell : Other, Odorless Salt Composition : Bortezomib Physical Color/Texture : Other , White to offwhite lyophilized powder Indication : Multiple Myeloma, Mantle Cell Lymphoma Application : Other, Anticancer Therapy Ingredients : Other , Bortezomib Storage Instructions : Store below 25C, protect from light Feature : Other, Lyophilized, singleuse vial Enzyme Types : Other, Proteasome Inhibitor

Send Inquiry

Fulvenat Injection Dosage Form : Injection Shelf Life : 24 months Fermentation Smell : Other, Odorless Salt Composition : Fulvestrant 250 mg Physical Color/Texture : Other , Clear, colorless to yellowish oily solution Indication : Breast cancer (hormone receptorpositive metastatic breast cancer in postmenopausal women) Application : Other, Hospital, clinical use for oncology treatment Ingredients : Other , Fulvestrant Storage Instructions : Store below 30C, protect from light and do not freeze Feature : Other, Antineoplastic, estrogen receptor antagonist

Send Inquiry

SEND INQUIRY CALL ME FREE